1 recruiting, 1 terminated. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Terminated 1 |
| Phase 3 | 2 | Recruiting 1, Terminated 1 |
Follow Emetine: new trials by email Literature Review of Emetine trials Research Report on Emetine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Emetine for Viral Outbreaks (a.k.a. EVOLVE Antiviral Initiative) Emetine Hydrochloride 6mg, Placebo, Emetine Hydrochloride 12mg - Dengue | Phase 2 / Phase 3 | Recruiting | Johns Hopkins University | 600 | 2026-09-01 | 2026-10-13 |
| Evaluating Emetine for Viral Outbreaks (EVOLVE) Emetine Hydrochloride, Placebo - COVID-19 | Phase 2 / Phase 3 | Terminated | Johns Hopkins University | 4 | 2024-05-15 | 2026-01-23 |
Nepal (2) · United States (2)
Kunchok Dorjee, MBBS, PhD (1) · Kunchok Dorjee, MBBS, PhD, MPH (1)